Cyngn Schedules 2021 Third Quarter Financial Results Release and Conference Call
09 Novembre 2021 - 2:30PM
Business Wire
Cyngn (or the “Company”) (NASDAQ: CYN), a developer of
innovative autonomous driving software solutions for industrial and
commercial enterprises, today announced that it will release
financial results for the third quarter and nine months ended
September 30, 2021, after the close of the stock market on
Wednesday, November 17, 2021. The Company will discuss those
results in a conference call at 2 p.m. PT/5 p.m. ET that same
day.
Participant Dial-in Numbers
U.S. & Canada (Toll-Free): (877) 407-9753 International
(Toll): (201) 493-6739
To access the call, please dial in approximately five minutes
before start time.
Webcast
The call will also be available via online webcast at:
https://78449.themediaframe.com/dataconf/productusers/cyn/mediaframe/47383/indexl.html.
Those who are unable to attend the live conference call may
access the recording shortly after the conclusion of the call at
the above webcast link or at the “Investor Relations” page of the
Company’s website (https://investors.cyngn.com/).
About Cyngn
Cyngn is a Silicon Valley-based autonomous vehicle technology
company. Its Enterprise Autonomy Suite (EAS) unifies robotaxi-level
autonomous driving software, off-the-shelf leading hardware, and
precise analytics to deliver the first of its kind autonomous
vehicle solution for industrial fleets. Cyngn’s flexible, scalable
technology transforms industrial vehicles into a fully-integrated
self-driving fleet of the future. To learn more, please visit
www.cyngn.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211109005622/en/
Carolyne Sohn Vice President, The Equity Group
csohn@equityny.com (415) 568-2255
Grafico Azioni Cynapsus Therapeutics Inc. (NASDAQ:CYNA)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Cynapsus Therapeutics Inc. (NASDAQ:CYNA)
Storico
Da Giu 2023 a Giu 2024
Notizie in Tempo Reale relative a Cynapsus Therapeutics Inc. (MM) (NASDAQ): 0 articoli recenti
Più Cynapsus Therapeutics Inc. (MM) Articoli Notizie